FDA panel votes against MDMA therapy for PTSD, citing muddy data and safety concerns
Bio Pharma Dive
JUNE 4, 2024
A group of independent experts wasn't convinced by clinical trial data from company Lykos Therapeutics, which is seeking FDA approval of MDMA-assisted treatment for post-traumatic stress disorder.
Let's personalize your content